Effector memory cytotoxic CD3+/CD8+/CD45RO+ T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer
Xiangjie Sun, Jie Zhai, Baohua Sun, Edwin R. Parra, Mei Jiang, Wencai Ma, Jing Wang, Anthony Kang, Kasthuri Kannan, Renganayaki Pandurengan, Shanyu Zhang, Luisa M. Solis, Cara Haymaker, Maria Gabriela Raso, Julia Mendoza Perez, Ayşegül A. Şahin, Ignacio I. Wistuba, Clinton Yam, Jennifer K. Litton, Fei Yang
Topics & Concepts
CD8Cytotoxic T cellBreast cancerTriple-negative breast cancerImmune systemTumor-infiltrating lymphocytesGranzyme BMedicineCD3T cellFOXP3Stromal cellOncologyInternal medicineCancer researchPathologyImmunologyCancerBiologyIn vitroBiochemistryCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy research